Logo

Zevra Therapeutics, Inc.

ZVRA

Zevra Therapeutics, Inc., a rare disease company melding science, discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company utilizes its Ligand Activated Therapy technology to generate improved prodrug versions of FDA-approved drugs, as well as to generate prodrug versions of existing compounds that may have applications for new disea… read more

Healthcare

Biotechnology

8 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$9.43

Price

+5.96%

$0.53

Market Cap

$529.354m

Small

Price/Earnings

-

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$40.588m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$91.988m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

-$1.90

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$41.023m

$172.708m

Assets

$131.685m

Liabilities

$61.837m

Debt
Debt to Assets

35.8%

-1x

Debt to EBITDA
Free Cash Flow

-$61.821m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
Press Releases
Statements and updates from the company
↑ TopSummaryPriceFinancialsPress Releases